Nothing Special   »   [go: up one dir, main page]

ATE333867T1 - Emulgierte arzneistoffabgabesysteme - Google Patents

Emulgierte arzneistoffabgabesysteme

Info

Publication number
ATE333867T1
ATE333867T1 AT95913757T AT95913757T ATE333867T1 AT E333867 T1 ATE333867 T1 AT E333867T1 AT 95913757 T AT95913757 T AT 95913757T AT 95913757 T AT95913757 T AT 95913757T AT E333867 T1 ATE333867 T1 AT E333867T1
Authority
AT
Austria
Prior art keywords
pct
emulsion
drug delivery
delivery systems
phase
Prior art date
Application number
AT95913757T
Other languages
English (en)
Inventor
Edward M Rudnic
John A Mccarty
Beth A Burnside
Charlotte M Mcguinness
George W Belenduik
Original Assignee
Shire Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Lab Inc filed Critical Shire Lab Inc
Application granted granted Critical
Publication of ATE333867T1 publication Critical patent/ATE333867T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95913757T 1994-03-18 1995-03-17 Emulgierte arzneistoffabgabesysteme ATE333867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21035194A 1994-03-18 1994-03-18

Publications (1)

Publication Number Publication Date
ATE333867T1 true ATE333867T1 (de) 2006-08-15

Family

ID=22782568

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95913757T ATE333867T1 (de) 1994-03-18 1995-03-17 Emulgierte arzneistoffabgabesysteme

Country Status (9)

Country Link
US (2) US5952004A (de)
EP (1) EP0788346B9 (de)
JP (2) JP4157969B2 (de)
AT (1) ATE333867T1 (de)
AU (1) AU696855B2 (de)
CA (1) CA2185803C (de)
DE (1) DE69535127T2 (de)
ES (1) ES2270426T3 (de)
WO (1) WO1995025504A1 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
WO1997002815A1 (fr) * 1995-07-07 1997-01-30 Nippon Kayaku Kabushiki Kaisha Composition de flutamide
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CZ267796A3 (cs) 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US20030105156A1 (en) * 1997-01-07 2003-06-05 Nagesh Palepu Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
ES2226205T3 (es) 1997-12-19 2005-03-16 Taro Pharmaceuticals U.S.A., Inc. Formulaciones topicas de carbamazepina y procedimiento de utilizacion.
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
AR018376A1 (es) * 1998-05-26 2001-11-14 Novartis Ag Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
JP2002531515A (ja) * 1998-12-11 2002-09-24 ファーマソリューションズ・インコーポレイテッド 水に難溶性の薬剤のための自己乳化組成物
ES2265946T3 (es) * 1999-06-04 2007-03-01 Abbott Laboratories Formulaciones farmaceuticas mejoradas que contienen ritonavir.
US7141593B1 (en) 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations
JP2003516345A (ja) * 1999-12-09 2003-05-13 アルザ・コーポレーション 抗ウイルス剤
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
WO2001080897A2 (en) * 2000-04-21 2001-11-01 Vical Incorporated Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
AU2002214861B2 (en) * 2000-11-07 2006-09-28 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
KR100736115B1 (ko) * 2000-11-07 2007-07-06 엘지.필립스 엘시디 주식회사 액정 광학필름
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
EP1363622A4 (de) * 2001-02-01 2005-04-13 Shire Lab Inc Pharmazeutische zusammensetzungen mit sampatrilat, dispergiert in einem lipoid-träger
US6730330B2 (en) 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
AU2002231970B2 (en) * 2001-02-14 2007-08-16 GW Research Limited Mucoadhesive pharmaceutical formulations
US10004684B2 (en) 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
FR2828102B1 (fr) * 2001-03-28 2004-07-09 Ifc Sa Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes
WO2002087621A1 (en) * 2001-04-30 2002-11-07 Shire Laboratories Inc. Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US7237679B1 (en) 2001-09-04 2007-07-03 Aveka, Inc. Process for sizing particles and producing particles separated into size distributions
EP1435910B9 (de) * 2001-10-19 2010-02-03 Isotechnika Inc. Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2002357012A1 (en) * 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
EP1461044A4 (de) * 2001-12-03 2007-06-13 Novacea Inc Pharmazeutische zusammensetzungen mit aktiven vitamin-d-verbindungen
FR2834215B1 (fr) * 2001-12-27 2004-07-16 Physica Composes amphiphiles a usage pharmaceutique ou cosmetique
ES2524000T3 (es) * 2002-06-05 2014-12-03 Teva Czech Industries S.R.O. Reducción de la reticulación de la gelatina
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US8211448B2 (en) * 2003-07-07 2012-07-03 Nares Ab Microemulsions and its use for preventing airway diseases
JP2007500770A (ja) * 2003-07-28 2007-01-18 マリンクロッド・インコーポレイテッド 改善されたステアレート組成物およびその製法
US20050074469A1 (en) * 2003-10-03 2005-04-07 Charles Signorino Stable lipophilic emulsions for acrylic coating and method of making
US7498309B2 (en) 2003-11-29 2009-03-03 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents
EP1694304A2 (de) * 2003-12-04 2006-08-30 Pfizer Products Inc. Multiteilchenförmige dosierformen von azithromycin durch verfahren auf flüssigkeitsbasis
PT1691787E (pt) * 2003-12-04 2008-09-02 Pfizer Prod Inc Método de formação de multipartículas farmacêuticas
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
ATE498395T1 (de) * 2003-12-31 2011-03-15 Cima Labs Inc Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
GB2411355B (en) * 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US20050232974A1 (en) * 2004-04-19 2005-10-20 Gore Makarand P System and a method for pharmaceutical dosage preparation using jettable microemulsions
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20080096979A1 (en) * 2004-11-08 2008-04-24 Rubicon Research Pvt. Ltd. Aqueous Pharmaceutical Coating
WO2006061827A1 (en) * 2004-12-06 2006-06-15 Nutralease Ltd. Microemulsion comprising carbamazepine having solubility
JP2006232755A (ja) * 2005-02-25 2006-09-07 Dai Ichi Kogyo Seiyaku Co Ltd 油中水型マイクロエマルション
US20060240108A1 (en) * 2005-04-26 2006-10-26 Bernard Bobby L Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
US8851294B2 (en) 2005-05-25 2014-10-07 W. L. Gore & Associates, Inc. Aqueous delivery system for low surface energy structures
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20070104741A1 (en) * 2005-11-07 2007-05-10 Murty Pharmaceuticals, Inc. Delivery of tetrahydrocannabinol
WO2007059372A2 (en) * 2005-11-09 2007-05-24 St. Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
US8124598B2 (en) * 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
US20090060993A1 (en) * 2007-09-04 2009-03-05 Joseph Schwarz Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20090123537A1 (en) * 2007-11-12 2009-05-14 Debrouse Daniel R Oral dosage form of ceftriaxone and methods of use
US20100004345A1 (en) * 2008-07-01 2010-01-07 Signorino Charles A High gloss non-stick film coating compositions
AU2009279372A1 (en) 2008-08-06 2010-02-11 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating psychiatric disorders
CN102307576A (zh) 2008-12-15 2012-01-04 班纳制药公司 用于增强水不溶性活性剂的释放和吸收的方法
JP5568093B2 (ja) * 2008-12-18 2014-08-06 ビーエーエスエフ ソシエタス・ヨーロピア 農薬粒子と両親媒性物質とを含む水性分散液
AU2010221209C1 (en) * 2009-03-06 2015-09-03 Tamarisk Technologies Group, L.L.C. Microencapsulated bioactive agents for oral delivery and methods of use thereof
WO2010114770A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-agent conjugates, particles, compositions, and related methods of use
WO2010114768A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-epothilone conjugates, particles, compositions, and related methods of use
MX2011010390A (es) * 2009-03-30 2011-12-14 Cerulean Pharma Inc Conjugados, particulas, composiciones de agentes polimericos y metodos relacionados de uso.
EP2301523A1 (de) * 2009-09-22 2011-03-30 Dr. August Wolff GmbH & Co. KG Arzneimittel Galenische Formulierung in kolloidaler Form
CN101756900B (zh) * 2010-02-25 2012-05-30 谢恬 一种榄香烯微乳
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
AU2012328739B2 (en) 2011-10-25 2017-11-30 Prothena Biosciences Limited Antibody formulations and methods
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
ES2498521B1 (es) * 2013-02-20 2015-08-18 Fundación Pública Andaluza Para La Investigación De Málaga En Biomedicina Y Salud (Fimabis) Formulaciones basadas en nanoemulsiones y su uso para el tratamiento de la obesidad
CN105050582B (zh) 2013-03-15 2018-11-30 W.L.戈尔及同仁股份有限公司 用于低表面能结构的水性递送体系
WO2015065180A1 (en) 2013-10-29 2015-05-07 Echo Pharmaceuticals B.V. Compressed tablet containing delta 9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
WO2015073736A1 (en) 2013-11-13 2015-05-21 Arbor Pharmaceuticals, Llc Methods and compositions for treating adhd
EP2878311A1 (de) 2013-11-27 2015-06-03 Freund Pharmatec Ltd. Verbesserung der Löslichkeit für hydrophobe Wirkstoffe
AU2016288643A1 (en) 2015-07-02 2018-02-22 University Of Louisville Research Foundation, Inc. Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer
AU2018221739A1 (en) * 2017-02-15 2019-08-29 Molecular Infusions, Llc Formulations
EP3424493A1 (de) 2017-07-07 2019-01-09 SolMic Research GmbH Stabile cannabinoide zusammensetzungen
BR102020010237A2 (pt) * 2020-05-22 2021-12-07 Ouro Fino Saúde Animal Ltda Plataforma para mascaramento de sabor

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
US4606913A (en) * 1978-09-25 1986-08-19 Lever Brothers Company High internal phase emulsions
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4690775A (en) * 1983-09-30 1987-09-01 Research Corporation Emulsion-based gel and process for preparing same
EP0212875A3 (de) * 1985-08-12 1988-06-15 William Gough Tucker Arzneimittel, sowie Verfahren zu deren Herstellung
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid
EP0327280B1 (de) * 1988-01-29 1992-03-18 Sankyo Company Limited Cyclosporin-Zusammensetzungen
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
ATE183099T1 (de) * 1991-04-19 1999-08-15 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
AU667483B2 (en) * 1991-07-26 1996-03-28 Smithkline Beecham Corporation W/O microemulsions
EP0597007B1 (de) * 1991-07-26 1996-10-16 Smithkline Beecham Corporation W/o mikroemulsionen
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
WO1994008605A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Therapeutic microemulsions
WO1994008610A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Pharmaceutical emulsion compositions
DE69329430T2 (de) * 1992-10-16 2001-05-10 Ibah, Inc. Konvertierbare mikroemulsionsformulierungen
JPH08507078A (ja) * 1993-02-17 1996-07-30 スミスクライン・ビーチャム・コーポレイション 治療用ペプチド含有のミクロエマルジョン
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems

Also Published As

Publication number Publication date
EP0788346B9 (de) 2007-02-14
DE69535127T2 (de) 2007-02-15
EP0788346A4 (de) 1998-05-06
AU696855B2 (en) 1998-09-17
JPH09510712A (ja) 1997-10-28
AU2102495A (en) 1995-10-09
JP2006022112A (ja) 2006-01-26
EP0788346A1 (de) 1997-08-13
JP4157969B2 (ja) 2008-10-01
CA2185803A1 (en) 1995-09-28
EP0788346B1 (de) 2006-07-26
US5897876A (en) 1999-04-27
US5952004A (en) 1999-09-14
DE69535127D1 (de) 2006-09-07
ES2270426T3 (es) 2007-04-01
CA2185803C (en) 2006-07-11
WO1995025504A1 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
MX9709028A (es) Suministro de aciclovir oral.
MX9307256A (es) Dispositivo de administracion que tiene excipientes capsulados.
TW347339B (en) Oral delivery of discrete units
DE69326350D1 (de) Pharmazeutische formulierung
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
ATE149828T1 (de) Arzneistofformulierung zur parenteralen anwendung
ES2053198T3 (es) Sistema de suministro de un farmaco de glucano y adyuvante.
ATE190225T1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
PT984762E (pt) Configuracoes de controlador de debito para um dispositivo de administracao de agente activo
CA2267083A1 (fr) Procede de liberation d'un principe actif contenu dans une emulsion multiple
ES2131804T3 (es) Sistema de dosificacion implantable.
FI944441A (fi) Määriteltyjä lipidejä sisältävä farmaseuttinen kantojärjestelmä
ES2162262T3 (es) Dispositivo para la administracion de agentes activos.
MY137749A (en) New self emulsifying drug delivery system
FI903483A0 (fi) Tretinoin innehaollande stabila emulsionskraemformulationer.
PT799035E (pt) Emulsao adequada para administracao de um esfingolipido e respectiva utilizacao
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
AU4975700A (en) Absorbent article comprising topsheet with low surfactant or no synthetic surfactant
FR2729575B1 (fr) Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type glycosaminoglycane anionique de basse masse moleculaire

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties